Drupal.behaviors.print = function(context) {window.print();window.close();}>
CombiMatrix to Introduce Gene-Mutation Testing; Q2 Revenues Climb 31 Percent
August 16, 2011
CombiMatrix to Introduce Gene-Mutation Testing; Q2 Revenues Climb 31 Percent
Full-text access for premium subscribers only.
Existing premium subscribers
login here
.
New to GenomeWeb?
Register here
quickly.
Related Stories
CombiMatrix Sees Focus on CMA Pay off as it Reports 172 Percent Q4 Prenatal Testing Growth
January 8, 2013 / BioArray News
Autism-Associated Variants Uncovered by Population Diagnostics, SickKids Team Could Yield Dx Tests
December 11, 2012 / BioArray News
CombiMatrix Bets on Array-Based Prenatal Testing, Affy Clinical Trials Deal to Drive Growth in H2
August 14, 2012 / BioArray News
New Products: GeneDx's Familial Cerebral Cavernous Malformations Test; CTGT's Osteogenesis Imperfecta Test
February 7, 2012 / BioArray News
CombiMatrix Shares up Sharply as Firm Reports Record Prenatal Testing Volumes in Preliminary Q1 Results
April 4, 2013 / GenomeWeb Daily News